4-hydroxymercuribenzenesulfonate

an oxidizing sulfhydryl (-SH) reagent; structure

Also Known As:

PHMPS; hydroxy(4-sulfophenyl)mercury; hydroxymercury benzenesulfonic acid; p-hydroxy-mercuric-phenylsulfonic acid; p-hydroxymercuriphenylsulfonate; para-hydroxymercuribenzenesulfonate

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - Organomercury Compounds: 3
    - Phenylmercury Compounds
      - 4-hydroxymercuribenzenesulfonate: 3

Related Diseases

1.	Neoplasms (Cancer) 01/01/1991 - "Apyrase caused a nonsignificant reduction in the aggregation response, hirudin did not change it, while iodoacetic acid or p-hydroxymercuriphenylsulfonate, specific cysteine proteinase inhibitors, significantly reduced the platelet-aggregating capacity of these tumor cells. "
2.	Contracture 03/01/1993 - "After losing their ability to contract in response to electrical stimulation, the fibers maintain their capacity to develop caffeine contractures, even after prolonged periods (120 min) of exposure to PHMPS. "
3.	Hypoxia (Hypoxemia) 12/01/1998 - "pHMPS suppressed DPOAE completely at all sound intensities tested (45-80 dB SPL), whereas furosemide or lethal anoxia caused DPOAE to disappear at low-level stimulation (45-60 dB SPL) only. " 12/01/1998 - "The effect of pCMPS and pHMPS was different from the effects of furosemide and lethal anoxia, which impair cochlear function but do not block OHC electromotility. "

Related Drugs and Biologics

1.	Iodoacetic Acid
2.	Cysteine Proteinase Inhibitors
3.	Hirudins
4.	Furosemide (Lasix)
5.	4-Chloromercuribenzenesulfonate (4 Chloromercuribenzenesulfonate)
6.	Caffeine (No Doz)
7.	Apyrase (ATP Diphosphatase)